Recombinant multi-species KMT2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
The Alternative Names of target: AAD10,ALL1-related protein,ALR,BCAHH,C430014K11Rik,CAGL114,Histone-lysine N-methyltransferase 2D,KABUK1,KMS,KMT2B,KMT2D,Kmt2d,Lysine N-methyltransferase 2D,MLL2,MLL4,Mll2,Mll4,Myeloid/lymphoid or mixed-lineage leukemia protein 2,TNRC21,bapa

Target products collectionGo to KMT2D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2567-Ag-1/ GM-Tg-hg-IP2567-Ag-2 Human KMT2D protein Human
GM-Tg-rg-IP2567-Ag-1/ GM-Tg-rg-IP2567-Ag-2 Rat KMT2D protein Rat
GM-Tg-mg-IP2567-Ag-1/ GM-Tg-mg-IP2567-Ag-2 Mouse KMT2D protein Mouse
GM-Tg-cynog-IP2567-Ag-1/ GM-Tg-cynog-IP2567-Ag-2 Cynomolgus/Rhesus macaque KMT2D protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2567-Ag-1/ GM-Tg-felg-IP2567-Ag-2 Feline KMT2D protein Feline
GM-Tg-cang-IP2567-Ag-1/ GM-Tg-cang-IP2567-Ag-2 Canine KMT2D protein Canine
GM-Tg-bovg-IP2567-Ag-1/ GM-Tg-bovg-IP2567-Ag-2 Bovine KMT2D protein Bovine
GM-Tg-equg-IP2567-Ag-1/ GM-Tg-equg-IP2567-Ag-2 Equine KMT2D protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2567-Ag-1/ GM-Tg-hg-IP2567-Ag-2; GM-Tg-rg-IP2567-Ag-1/ GM-Tg-rg-IP2567-Ag-2;
GM-Tg-mg-IP2567-Ag-1/ GM-Tg-mg-IP2567-Ag-2; GM-Tg-cynog-IP2567-Ag-1/ GM-Tg-cynog-IP2567-Ag-2;
GM-Tg-felg-IP2567-Ag-1/ GM-Tg-felg-IP2567-Ag-2; GM-Tg-cang-IP2567-Ag-1/ GM-Tg-cang-IP2567-Ag-2;
GM-Tg-bovg-IP2567-Ag-1/ GM-Tg-bovg-IP2567-Ag-2; GM-Tg-equg-IP2567-Ag-1/ GM-Tg-equg-IP2567-Ag-2
Products Name KMT2D protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KMT2D
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT2D protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.